PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company P/E ratio

Procter & Gamble Company's P/E ratio is 24.50: its share price of 165.39 over its earnings per share of 6.75 over the last twelve months.

Today
24.50
Forward P/E, next 12 months
23.19
PEG ratio
8.06
Median, 5 years
24.83
Low, 5 years
19.63
High, 5 years
30.21

P/E ratio = price ÷ EPS (last 12 months) = 165.39 ÷ 6.75 = 24.50

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Procter & Gamble Company's P/E high compared with its own history?

Procter & Gamble Company's P/E of 24.5 is around the middle of its 5-year range (19.6 to 30.2, median 24.8). It is in line with its own history.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2028 · Estimate30 Jun 202822.34———
FY2027 · Estimate30 Jun 202723.71———
Today24.5023.19383.34B16.12B
FY202630 Jun 202622.0021.00355.24B16.14B
FY202530 Jun 202524.3423.17391.04B16.07B
FY202430 Jun 202425.6524.34384.04B14.97B
FY202330 Jun 202324.3825.50359.35B14.74B
FY202230 Jun 202223.8824.58353.29B14.79B
FY202130 Jun 202123.6423.17339.25B14.35B
FY202030 Jun 202023.1721.33303.63B13.10B
FY201930 Jun 201969.7522.02276.62B3.97B
FY201830 Jun 201820.0217.46197.44B9.86B
FY201730 Jun 201714.7718.93226.42B15.33B
FY201630 Jun 201622.0818.93234.13B10.60B
FY201530 Jun 201530.8221.56220.20B7.14B
FY201430 Jun 201418.5321.66218.38B11.79B
FY201330 Jun 201319.1619.65218.46B11.40B
FY201230 Jun 201215.8217.49172.46B10.90B
FY201130 Jun 201114.9516.43178.25B11.93B
FY201030 Jun 201013.8816.61176.83B12.74B
FY200930 Jun 200911.3813.41152.91B13.44B
FY200830 Jun 200815.5115.39187.34B12.08B
FY200730 Jun 200718.6919.07193.30B10.34B
FY200630 Jun 200619.5620.52169.85B8.68B
FY200530 Jun 200519.1720.77132.70B6.92B
FY200430 Jun 200421.6722.68140.46B6.48B
FY200330 Jun 200322.3020.55115.63B5.19B
FY200230 Jun 200226.8424.02116.82B4.35B
FY200130 Jun 200128.1819.9182.33B2.92B
FY200030 Jun 200020.9617.8774.23B3.54B
FY199930 Jun 199930.9930.34116.62B3.76B
FY199830 Jun 199835.1634.50132.89B3.78B
FY199730 Jun 199728.8027.8298.35B3.42B
FY199630 Jun 199620.69—63.04B3.05B
FY199530 Jun 199518.51—48.95B2.65B
FY199430 Jun 199416.40—36.26B2.21B
FY199330 Jun 1993132.18—35.56B269.00M
FY199230 Jun 199216.55—30.97B1.87B
FY199130 Jun 199115.33—27.18B1.77B
FY199030 Jun 199018.57—29.75B1.60B
FY198930 Jun 198914.90—17.97B1.21B
FY198830 Jun 198812.83—13.08B1.02B
FY198730 Jun 198748.96—16.01B327.00M
FY198630 Jun 198618.62—13.20B709.00M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Procter & Gamble Company's P/E ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.